Member
Since
3
Yrs
Mylan Technologies Inc.
110 Lake Street
St. Albans, Vermont-05478, USA

Emsam

FOB Price : Get Latest Price
Product Details
Next Product

somerset pharmaceuticals, inc. , a wholly owned subsidiary of mylan inc. ,
received approval from the fda for emsam® transdermal
selegiline, on february 27 of 2006. Emsam® is the
first transdermal treatment for major depressive disorder. All aspects of the
emsam® product related to its design, chemistry,
manufacturing and controls were the result of the integration of the talents
and expertise of mti scientists. Emsam® is
manufactured by mti.


antidepressants increased the risk of suicidal thinking and behavior
(suicidality) in short-term studies in children and adolescents with major
depressive disorder (mdd) and other psychotic disorders. Anyone considering the
use of emsam® or other antidepressants in a child or
adolescent must balance this risk with the clinical need.


emsam® is not indicated for use in pediatric patients.


for additional details please see full prescribing information, including boxed
warnings.





 
More Products From This Supplier
 
 
Recommended Product
 
 

sending enquiry
Thank You Close X
You may also visit more related suppliers as given below :

unable to instantiate your call right now. please try after some time.

close

© Copyright HelloTrade.com